1-12 of 12
Evelyn Acuña-Cruz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multicenter, Prospective, Non-Randomized, Phase I-II Trial to Asses the Efficacy and Safety of the Combination or Oral Quizartinib and the FLAG-IDA Chemotherapy Regimen in First Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Javier Martinez Zambrano, Teresa Bernal, Rebeca Rodriguez-Veiga, Jose Antonio Perez Simon, Montserrat Arnan, Susana Vives, Juan Miguel Bergüa Burgues, Joaquin Martinez Lopez, Vicente Rubio, Joaquin Sanchez-Garcia, Josefina Serrano, Ainhoa Fernandez Moreno, Andres Novo Garcia, Inmaculada Marchante Cepillo, Pilar Herrera Puente, Carlos Rodriguez Medina, Laura Torres Miñana, Victor Noriega Concepcion, Marta Cervera Calvo, Ana Alfonso Pierola, Evelyn Acuña-Cruz, Isabel Cano-Ferri, Maria Teresa Gómez Casares, David Martinez-Cuadron, Pau Montesinos
Journal: Blood
Blood (2024) 144 (Supplement 1): 2874.
https://doi.org/10.1182/blood-2024-200280
Published: 2024
Journal Articles

Single-Cell Multiomics Data-Driven Measurable Residual Disease (MRD) Assessment Using Multidimensional Flow Cytometry (MFC) in Acute Myeloid Leukemia (AML)

Carmen Gonzalez, Catia Simoes, Leire Burgos, David Martinez-Cuadron, Sarai Sarvide, Diego Alignani, Aitziber Lopez, Yujuan Gui, Hana Komic, Tessa Schmachtel, Carmen Botella, Raimundo Garcia Boyero, Esther Perez Santaolla, Cristina Gil, Jesús Lorenzo Algarra, Maria Jose Sayas Lloris, Francisco Ibañez, Laura Torres, Isabel Cano-Ferri, Evelyn Acuña-Cruz, Olga Arce, Fredrik B. Thorén, Michael A. Rieger, Jesús F. San-Miguel, Felipe Prosper, Pau Montesinos, Bruno Paiva
Journal: Blood
Blood (2024) 144 (Supplement 1): 4328.
https://doi.org/10.1182/blood-2024-203076
Published: 2024
Journal Articles

A High Percentage of DNAM-1+ and Low Percentage of Tactile+ NK Cells at Diagnosis Correlate with Complete Response and Survival in AML: A Sub-Analysis of the Ven-a-Qui Pethema Trial

Juan Miguel Bergua Burgues, Raquel Tarazona, Javier Garcia Casado, Juan J Gordillo, Ignacio Casas Aviles, Rebeca Rodriguez Veiga, Isabel Cano, Ferran Vall-Llovera Calmet, Antonio Garcia, Joaquin Gomez Espuch, Mercedes Colorado, Jordi Esteve, Victoria Verdugo Cabeza De Vaca, Maria Antonia Sanpol, Fernando Ramos, Marta Valero, Evelyn Acuña-Cruz, Blanca Boluda, Joaquin Martinez-Lopez, Rosa Ayala, Eva Barragán, David Martinez-Cuadron, Pau Montesinos
Journal: Blood
Blood (2023) 142 (Supplement 1): 2960.
https://doi.org/10.1182/blood-2023-189676
Published: 2023
Journal Articles

Indolent Acute Myeloid Leukemia with Long Survival in Patients Treated with Best Supportive Care Only: A Pethema Registry Study

Jorge Labrador, Josefina Serrano, Laura Torres, Evelyn Acuña-Cruz, Jose A. Perez-Simon, Maria Lopez-Pavia, Gabriela Rodriguez Macias, Carmen Botella, Carlos Rodriguez, Pilar Martinez Sanchez, Maria Luz Amigo, Maria Victoria Cuevas, Teresa Bernal del Castillo, María Carmen Montes, Celina Benavente, Juan Ignacio Rodriguez-Gutierrez, Mar Tormo, Raimundo García-Boyero, Aurelio Lopez Martínez, Rafael Lluch Garcia, Jesús Lorenzo Algarra, Esperanza Lavilla, David Martinez-Cuadron, Miguel A. Sanz, Pau Montesinos
Journal: Blood
Blood (2022) 140 (Supplement 1): 8919–8920.
https://doi.org/10.1182/blood-2022-162591
Published: 2022
Journal Articles

Iadademstat Combination with Azacitidine Is a Safe and Effective Treatment in First Line Acute Myeloid Leukemia. Final Results of the Alice Trial

Olga Salamero, Tim C.P Somervaille, Antonieta Molero, Evelyn Acuña-Cruz, Jose A. Perez-Simon, Rosa Coll, Montserrat Arnan, Brayan Merchan, Ana Perez, Isabel Cano, Rebeca Rodríguez-Veiga, Mabel Arevalo, Sonia Gutierrez, Carlos Buesa, Douglas V Faller, Francesc Bosch, Pau Montesinos
Journal: Blood
Blood (2022) 140 (Supplement 1): 1711–1713.
https://doi.org/10.1182/blood-2022-168945
Published: 2022
Journal Articles

A Study of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate, for Patients with Frontline and Relapsed/Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Naveen Pemmaraju, Giovanni Marconi, Elisabetta Todisco, Pau Montesinos, Andrew A. Lane, Kendra Sweet, Eunice S. Wang, Eric Deconinck, David A Rizzieri, Roland B. Walter, Ahmed Aribi, Delphine Lebon, Moshe Y. Levy, Luca Mazzarella, Giovanni Martinelli, Federica Gigli, Harry P. Erba, Evelyn Acuña-Cruz, Marina Konopleva, Hagop Kantarjian, Callum M Sloss, Jiuzhou Wang, Kara E Malcolm, Patrick A Zweidler-McKay, Daniel J. DeAngelo, Naval Daver
Journal: Blood
Blood (2021) 138 (Supplement 1): 4429.
https://doi.org/10.1182/blood-2021-146681
Published: 2021
Journal Articles

Experience with IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Frontline Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Naveen Pemmaraju, Giovanni Martinelli, Elisabetta Todisco, Andrew A. Lane, Evelyn Acuña-Cruz, Eric Deconinck, Eunice S. Wang, Kendra Sweet, David A Rizzieri, Giovanni Marconi, Luca Mazzarella, Daniel J. DeAngelo, Pau Montesinos, Federica Gigli, Harry P. Erba, Marina Konopleva, Hagop Kantarjian, Roland B. Walter, Ahmed Aribi, Delphine Lebon, Moshe Y. Levy, Callum M Sloss, Kara E Malcolm, Patrick A Zweidler-McKay, Naval Daver
Journal: Blood
Blood (2021) 138 (Supplement 1): 1284.
https://doi.org/10.1182/blood-2021-146666
Published: 2021
Journal Articles

Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4

Sabine Kayser, David Martínez-Cuadrón, Maher Hanoun, Friedrich Stölzel, Cristina Gil, H. Christian Reinhardt, Eliana Aguiar, Kerstin Schäfer-Eckart, Juan Miguel Bergua Burgues, Björn Steffen, Teresa Bernal, Stefan W. Krause, Rosalia Riaza, Christoph Schliemann, Jose Cervera, Martin Kaufmann, Laura Torres, Mathias Haenel, Evelyn Acuña-Cruz, Edgar Jost, Jesús Lorenzo Algarra, Martina Crysandt, Lars Fransecky, Javier Cornago Navascués, Sabrina Kraus, Joaquin Martinez-Lopez, Hermann Einsele, Dirk Niemann, Andreas Neubauer, Ruth Seggewiss-Bernhardt, Sebastian Scholl, Stefan Klein, Christoph Schmid, Markus Schaich, Martin Schmidt-Hieber, Anthony D. Ho, Uwe Platzbecker, Claudia D. Baldus, Carsten Müller-Tidow, Christian Thiede, Martin Bornhäuser, Hubert Serve, Mark Levis, Pau Montesinos, Christoph Röllig, Richard F. Schlenk
Journal: Blood
Blood (2021) 138 (Supplement 1): 1307.
https://doi.org/10.1182/blood-2021-150281
Published: 2021
Journal Articles

Iadademstat in Combination with Azacitidine Generates Robust and Long Lasting Responses in AML Patients (ALICE Trial)

Olga Salamero, Tim C.P Somervaille, Antonieta Molero, Evelyn Acuña-Cruz, Jose Pérez-Simón, Rosa Coll, Montserrat Arnan Sangerman, Brayan Merchan, Ana Perez, Isabel Cano, Rebeca Rodríguez-Veiga, Sonia Gutierrez, Carlos Buesa, Francesc Bosch, Pau Montesinos
Journal: Blood
Blood (2021) 138 (Supplement 1): 3376.
https://doi.org/10.1182/blood-2021-152183
Published: 2021
Journal Articles

Clinical Profile of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Patients with Relapsed/Refractory (R/R) Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Naveen Pemmaraju, MD, Giovanni Martinelli, MD, Elisabetta Todisco, MDPhD, Andrew A Lane, MD PhD, Evelyn Acuña-Cruz, MD, Eric Deconinck, MDPhD, Eunice S. Wang, MD, Kendra L. Sweet, MD MS, David A Rizzieri, MD, Luca Mazzarella, MDPhD, Daniel J. DeAngelo, MD PhD, Pau Montesinos, MD PhD, Corrado Tarella, Harry P. Erba, MD PhD, Marina Konopleva, MD PhD, Hagop M. Kantarjian, MD, Callum M Sloss, PhD, Kara E Malcolm, RN, Patrick A Zweidler-McKay, MDPhD, Naval Daver, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–13.
https://doi.org/10.1182/blood-2020-139903
Published: 2020
Journal Articles

Ivosidenib Improves Overall Survival Relative to Standard Therapies in Relapsed or Refractory Mutant IDH1 AML: Results from Matched Comparisons to Historical Controls

Peter Paschka, MD, Hervé Dombret, MD, Xavier Thomas, MD PhD, Christian Recher, MD PhD, Sylvain Chantepie, MD, Pau Montesinos Fernandez, MD PhD, Evelyn Acuña-Cruz, MD, Paresh Vyas, MRCP, FRCP, FRCPath, Karl-Anton Kreuzer, MD, Michael Heuser, Klaus H. Metzeler, MD, Michael Dennis, MD, Bruno Quesnel, MD PhD, Mathilde Hunault-Berger, MDPhD, Mohamad Mohty, MD PhD, Arnaud Pigneux, MD PhD, Stephane De Botton, Daniela Weber, MSc, Konstanze Döhner, Gary Milkovich, PharmD, John Reitan, PharmD, Sarah C MacDonald, SD, Deborah Casso, MPH, Michael Storm, MSc, Hua Liu, PhD, Stephanie M. Kapsalis, BS, Eyal C. Attar, MD, Thomas Winkler, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-136957
Published: 2020
Journal Articles

Liposomal Doxorubicin in Aggressive B Cell Lymphoma Has Similar Efficacy to the Conventional Formulation: Results from a Retrospective Cohort Study

Evelyn Acuña Cruz, MD, Jimena Cannata Ortiz, MD, Ana García-Noblejas, MD, Adrian Alegre, Reyes Arranz Sáez, MD
Journal: Blood
Blood (2015) 126 (23): 5106.
https://doi.org/10.1182/blood.V126.23.5106.5106
Published: 2015